Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Hydroxychloroquine does not significantly reduce admission to intensive care or improve survival rates in patients hospitalised with pneumonia owing to COVID-19, a study published in the BMJ has found.

Nearly a third of community pharmacy staff who were temporarily added to the pharmacy register in response to the COVID-19 pandemic have either returned to work or are planning to do so soon, a survey has found.